Venetoclax targets BCL2 in chronic lymphocytic leukaemia.
作者信息
Brower Vicki
出版信息
Lancet Oncol. 2016 Jan;17(1):e11. doi: 10.1016/S1470-2045(15)00576-8. Epub 2015 Dec 11.
Abstract
摘要
相似文献
1
Venetoclax targets BCL2 in chronic lymphocytic leukaemia.
Lancet Oncol. 2016 Jan;17(1):e11. doi: 10.1016/S1470-2045(15)00576-8. Epub 2015 Dec 11.
2
New Agents to Treat Chronic Lymphocytic Leukemia.
N Engl J Med. 2016 Jun 2;374(22):2186-7. doi: 10.1056/NEJMc1602674.
3
New Agents to Treat Chronic Lymphocytic Leukemia.
N Engl J Med. 2016 Jun 2;374(22):2185. doi: 10.1056/NEJMc1602674.
4
Venetoclax (Venclexta) for chronic lymphocytic leukemia.
Med Lett Drugs Ther. 2016 Aug 1;58(1500):101-2.
5
Progress in Chronic Lymphocytic Leukemia with Targeted Therapy.
N Engl J Med. 2016 Jan 28;374(4):386-8. doi: 10.1056/NEJMe1515235.
6
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.
N Engl J Med. 2016 Jan 28;374(4):311-22. doi: 10.1056/NEJMoa1513257. Epub 2015 Dec 6.
7
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia.
Drugs Today (Barc). 2016 Apr;52(4):249-60. doi: 10.1358/dot.2016.52.4.2470954.
8
Venetoclax in the treatment of chronic lymphocytic leukemia.
Expert Opin Drug Metab Toxicol. 2019 May;15(5):353-366. doi: 10.1080/17425255.2019.1606211. Epub 2019 Apr 25.
9
A literature review of the patent publications on venetoclax - a selective Bcl-2 inhibitor: discovering the therapeutic potential of a novel chemotherapeutic agent.
Expert Opin Ther Pat. 2019 Jul;29(7):487-496. doi: 10.1080/13543776.2019.1627327. Epub 2019 Jun 7.
10
Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid Malignancies.
Ann Pharmacother. 2017 May;51(5):410-416. doi: 10.1177/1060028016685803. Epub 2017 Jan 6.
引用本文的文献
1
Venetoclax and low-dose cytarabine induced complete remission in a patient with high-risk acute myeloid leukemia: a case report.
Front Med. 2018 Oct;12(5):593-599. doi: 10.1007/s11684-018-0635-y. Epub 2018 May 21.
2
[Advances of therapeutic strategies in hematological malignancies].
Zhonghua Xue Ye Xue Za Zhi. 2016 Nov 14;37(11):1008-1011. doi: 10.3760/cma.j.issn.0253-2727.2016.11.018.
3
Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport.
Oncotarget. 2016 Aug 9;7(32):51435-51449. doi: 10.18632/oncotarget.9843.
Zotero 插件